Explained herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate medications, these types of devices including a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to